Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 13Lymphoma, Non-Hodgkin 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 6Leukemia, Lymphocytic, Chronic, B-Cell 6Sarcoma 5Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 5Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Hematologic Neoplasms 3Hematologic Diseases 3Breast Neoplasms 3Testicular Neoplasms 2Teratoma 2Retinoblastoma 2Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2

Interventions

Rituximab 57Cyclophosphamide 42fludarabine phosphate 29Peripheral Blood Stem Cell Transplantation 29Mycophenolic Acid 22Dexamethasone 21Tacrolimus 20Whole-Body Irradiation 18Bortezomib 18Cyclosporine 15Busulfan 13ibrutinib 12Methotrexate 12Melphalan 12Radiotherapy 11Etoposide 11Antilymphocyte Serum 10zanubrutinib 9Calcium Dobesilate 9venetoclax 7Sirolimus 7idelalisib 6Prednisone 6Lenalidomide 6Filgrastim 6Doxorubicin 6Cyclosporins 6Bendamustine Hydrochloride 6Alemtuzumab 6sargramostim 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Waldenstrom Macroglobulinemia × Mesna × Clear all
NCT00002829 2012-07-30

Bone Marrow Transplantation in Treating Patients With Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
45 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡